跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML
Approved
THERAPEUTIC
MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML
Baxter Pharmaceuticals India Private Limited
🇸🇬 Health Sciences Authority
Approval Date
Feb 8, 2018
Approval ID
4933f49d3c363b34
Company
Baxter Pharmaceuticals India Private Limited
Type
Therapeutic
Approval Details
Approval Id
4933f49d3c363b34
Drug Name
MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML
Product Name
MIDAZOLAM-BAXTER SOLUTION FOR INJECTION 5 MG/ML
Approval Number
SIN15419P
Approval Date
2018-02-08
Registrant
BAXTER HEALTHCARE (ASIA) PTE LTD
Licence Holder
BAXTER HEALTHCARE (ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR, RECTAL
Atc Code
N05CD08
Atc Item Name
midazolam
Pharma Manufacturer Name
BAXTER HEALTHCARE (ASIA) PTE LTD
Company Detail Path
/organization/baxter-healthcare-asia-pte-ltd
Active Ingredients
Midazolam HCl 5.56 mg eqv Midazolam
5mg/ml
MIDAZOLAM HCL 5.56 MG EQV MIDAZOLAM
5 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 8, 2018
Approval ID
4933f49d3c363b34
Type
Therapeutic
Back to HSA Approvals
